- IPGP grew by almost 10% in Q4 after nine straight quarterly contractions and the Q1 forecast calls for an acceleration in growth.
- Most major sales regions were still in negative territory, but sales growth of 52% in China more than made up for it.
- The stock has gotten ahead of the recovery at IPGP, even though there are risks out there that could spoil the party.
- IPGP needs to deliver on what the stock has assumed will happen or it could get punished with multiples having priced this in.
For further details see:
IPG Photonics May Not Yet Be Out Of The Woods Even Though It Has Pulled Itself Out Of A Hole